BioPharma Dive 6. Jan. 2026 CDC, following Trump’s orders, weakens US stance on childhood vaccinations
BioPharma Dive 5. Jan. 2026 Zenas shares crash after top drug misses expectations in immune disease study
BioPharma Dive 5. Jan. 2026 Strategic diagnostic testing partnerships are accelerating clinical research
BioPharma Dive 22. Dez. 2025 Biopharma climbs higher as 9 drugmakers ink ‘pandering’ drug price deals with Trump
BioPharma Dive 22. Dez. 2025 Trump to test ‘most favored nation’ pricing for Medicare; Shionogi pays $2.5B for ALS drug